Resolve Stroke
Driven by a powerful ambition to address unsolved medical issues, Resolve Stroke turns ultrasound into life-saving data. Resolve Stroke is at the forefront of a new healthtech field aimed at extracting drastically more information from ultrasound raw data leveraging software-based ultrasound systems. Resolve Stroke has now all the tools to be at the forefront of the next leap forward in medical imaging by seizing opportunities from currently accessible applications such as bedside neuro monitoring to future life-saving discoveries with new biomarkers.
Resolve Stroke
Driven by a powerful ambition to address unsolved medical issues, Resolve Stroke turns ultrasound into life-saving data. Resolve Stroke is at the forefront of a new healthtech field aimed at extracting drastically more information from ultrasound raw data leveraging software-based ultrasound systems. Resolve Stroke has now all the tools to be at the forefront of the next leap forward in medical imaging by seizing opportunities from currently accessible applications such as bedside neuro monitoring to future life-saving discoveries with new biomarkers.
TL;DR
What they do: Develop embedded software and AI to extract diagnostic data from ultrasound, initially focused on transcranial brain imaging for faster stroke diagnosis.
Headquarters: Paris, Île-de-France, France
Founders: Aritz Zamacola (CEO) and Vincent Hingot (CTO)
Funding highlights: Reported ~€3M pre-seed to date; documented €2.2M round (Sep 2023) and a €2.5M EIC Transition Grant (Jun 2025).
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Stroke diagnosis and neuroimaging at point-of-care (neurology, intensive care, emergency medicine).
Industry
Medical Equipment Manufacturing
Tech Stack
Funding Track Record
€2.2M
Round dated September 2023 with disclosed investors including OVNI Capital, Quantonation, Bpifrance, and Kima Ventures.
€2.5M
EIC Transition Grant awarded in June 2025 (non-dilutive).
Investor Signal
“Lead investors reported as OVNI Capital and Quantonation; other disclosed investors include Bpifrance and Kima Ventures.”